Sanara Medtech Inc (SMTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,836 | 176 | 331 | -416 | -1,341 |
| Depreciation Amortization | 120 | 57 | 81 | 61 | 60 |
| Accounts receivable | -324 | -1,337 | -64 | -353 | -181 |
| Accounts payable and accrued liabilities | -65 | 346 | 27 | 16 | 33 |
| Other Working Capital | 262 | 197 | -297 | -91 | -172 |
| Other Operating Activity | 676 | 1,079 | -218 | 1,192 | 397 |
| Operating Cash Flow | $-2,167 | $517 | $-140 | $409 | $-1,203 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -183 | -28 | -44 | -3 | -5 |
| Net Acquisitions | 509 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -1,523 | 0 | -42 | N/A | N/A |
| Other Investing Activity | -1,524 | 0 | -42 | 0 | 0 |
| Investing Cash Flow | $-1,197 | $-28 | $-86 | $-3 | $-5 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,200 | 0 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 1,296 |
| Debt Repayment | N/A | N/A | -195 | -205 | -1,179 |
| Common Stock Issued | 10,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -2,400 | 0 | 50 | 450 | 750 |
| Financing Cash Flow | $9,800 | $0 | $-145 | $245 | $867 |
| Beginning Cash Position | 176 | 463 | 834 | 182 | 523 |
| End Cash Position | 6,612 | 953 | 463 | 834 | 182 |
| Net Cash Flow | $6,436 | $489 | $-370 | $651 | $-341 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,167 | 517 | -140 | 409 | -1,203 |
| Capital Expenditure | -183 | -28 | -44 | -3 | -5 |
| Free Cash Flow | -2,350 | 489 | -184 | 406 | -1,208 |